{"nct_id":"NCT02015416","title":"A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2013-11","start_date_type":"ACTUAL","primary_completion_date":"2016-12","primary_completion_date_type":"ACTUAL","completion_date":"2017-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}